MCCULLOCH KEVIN (See Remarks) reported 1 transaction at XERIS BIOPHARMA HOLDINGS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/3/2025ACC: 0001867096-25-000060
Officer· See Remarks
Since Mar 2026
-733.00
Net shares
Net seller
$3.8K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
733.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−733.00
Price / share
$5.15
Trade value
$3.77K
% of position
0.0%
4/2/2025
1.68M→1.68M
Total
Net shares
−733.00
Net value
-$3.77K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/2/2025 | F · Tax Withholding | −733.00 | $5.15 | $3.77K | 0.0% | 1.68M | 1.68M |
| Total | −733.00 | -$3.77K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned2K
Common Stock
IndirectShares owned25K
Total
27K indirect27K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2K | Indirect |
| Common Stock | 25K | Indirect |
| Total | 27K | 27K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported